An aqueous extract from Hellenia speciosa, a plant used in traditional medicine, reduced liver damage and improved blood sugar control in diabetic rats, sometimes outperforming the diabetes drug metformin. In a 2026 study of 60 rats, the plant extract lowered fasting blood glucose from 310 to 218 mg/dL and reduced liver enzyme ALT from 91 to 48 U/L. According to Gram Research analysis, combining the extract with metformin produced the best results. However, these findings are from animal studies only, and human clinical trials are needed before any medical use can be recommended.
Researchers tested an extract from Hellenia speciosa, a plant used in traditional medicine for centuries, to see if it could protect the liver in rats with diabetes. According to Gram Research analysis, the plant extract reduced liver damage markers and improved blood sugar control, sometimes working better than the diabetes drug metformin. When combined with metformin, the results were even stronger. While these findings are encouraging, the study was done in rats, so more research in humans is needed before doctors could recommend this plant extract as a treatment.
Key Statistics
A 2026 animal study of 60 rats found that Hellenia speciosa extract reduced fasting blood glucose from 310 mg/dL to 218 mg/dL in diabetic rats, a 30% improvement compared to untreated diabetic controls.
Research published in the Journal of Ethnopharmacology showed that the plant extract reduced liver enzyme ALT from 91 U/L to 48 U/L in diabetic rats, indicating significant protection against liver damage.
A 2026 study comparing Hellenia speciosa extract to metformin found that the plant extract produced larger improvements in cellular protective pathways (Nrf2, HO-1, and NQO1) than metformin alone in diabetic rats.
When combined with metformin, Hellenia speciosa extract showed the most favorable metabolic profile in diabetic rats, suggesting the two treatments work through complementary mechanisms.
The Quick Take
- What they studied: Whether an extract made from Hellenia speciosa plant roots could reduce liver damage in rats with diabetes, and how it compared to metformin, a common diabetes medication.
- Who participated: 60 male rats divided into six groups. Some had normal health, while others were given a high-fat diet and a chemical to create diabetes similar to type 2 diabetes in humans.
- Key finding: Rats treated with the plant extract had significantly lower blood sugar levels (218 mg/dL versus 310 mg/dL), reduced liver damage markers, and less oxidative stress compared to untreated diabetic rats. The plant extract sometimes worked better than metformin alone.
- What it means for you: This research suggests the plant extract may help protect the liver in diabetes, but these are early findings in animals. Humans should not use this extract as a diabetes treatment yet. More research is needed to confirm safety and effectiveness in people.
The Research Details
Scientists divided 60 male rats into six groups. One group stayed healthy and served as a comparison. The other groups were fed a high-fat diet and given streptozotocin, a chemical that damages the pancreas to create diabetes. Some diabetic rats received the plant extract, some received metformin, some received both, and some received nothing. All treatments lasted six weeks. The researchers measured blood sugar, liver enzymes, oxidative stress (cellular damage), and looked at liver tissue under a microscope to see the damage.
The plant extract was carefully analyzed using a scientific method called HPLC to identify its active ingredients. The dose used was much higher than traditional medicine doses, which is important because higher doses might work differently than lower ones.
This type of study is called a preclinical animal study. It helps researchers understand whether a treatment might work before testing it in humans. However, results in rats do not always translate to humans.
Animal studies like this one help researchers understand how a potential treatment works and whether it is safe enough to test in humans. By comparing the plant extract to metformin, a well-known drug, the researchers could see if the extract offered any advantages. Testing at a high dose helped them understand the extract’s maximum potential effects.
Strengths: The study used a validated method to identify the plant extract’s ingredients, had a clear control group, and measured multiple markers of liver and metabolic health. Weaknesses: This was only done in rats, not humans. The dose used was much higher than traditional doses. The study was relatively short (six weeks). The researchers note these are association-level findings, meaning they show a relationship but do not prove the extract caused the improvements. More research is needed to understand how the extract works and whether it is safe for humans.
What the Results Show
Compared to untreated diabetic rats, those receiving the plant extract had significantly better results across multiple measures. Fasting blood sugar dropped from 310 mg/dL to 218 mg/dL. A measure called HOMA-IR, which shows how well the body handles insulin, improved dramatically from 58.3 to 24.0. Liver enzyme ALT, which indicates liver damage, fell from 91 U/L to 48 U/L.
The plant extract also reduced malondialdehyde, a marker of oxidative stress (cellular damage), from 4.4 to 3.1 nmol/mg protein. All of these improvements were statistically significant, meaning they were unlikely to happen by chance.
Interestingly, the plant extract produced larger changes in certain protective pathways (Nrf2, HO-1, and NQO1) compared to metformin. These pathways help cells defend against damage. However, metformin was better at lowering glucose and activating AMPK, another protective pathway.
When rats received both the plant extract and metformin together, they showed the best overall results, suggesting the two treatments work through different mechanisms and complement each other.
The plant extract improved mitochondrial function, the energy-producing structures inside cells. It also reduced markers of inflammation and oxidative stress throughout the liver tissue. Microscopic examination of liver tissue showed that the plant extract reduced the amount of fatty deposits and scarring in the liver, compared to untreated diabetic rats. These improvements suggest the extract protects liver cells from multiple types of damage caused by diabetes.
Hellenia speciosa has been used in Ayurvedic and traditional folk medicine for diabetes and liver problems for centuries, but this is the first study to test an aqueous extract against metformin in a controlled way. Previous research on related plants in the Costaceae family suggested they might have antioxidant and anti-inflammatory properties. This study provides the first chemical characterization of this specific extract and demonstrates its effects in a modern diabetes model that mimics human type 2 diabetes.
This study was conducted only in male rats, so results may not apply to females or to humans. The dose used was 4.5 to 9 times higher than traditional medicine doses, so we do not know if lower doses would work. The study lasted only six weeks, so long-term effects are unknown. The researchers could not prove that the extract caused the improvements, only that they were associated with the extract. The extract’s active ingredients have not been fully identified. Most importantly, animal studies often do not translate to humans, so human clinical trials are essential before any medical recommendation.
The Bottom Line
This research is preliminary and should not change anyone’s current diabetes treatment. People with diabetes should continue taking prescribed medications like metformin as directed by their doctor. The plant extract studied here is not yet available as a medical treatment. If future human studies confirm these findings, the extract might become a complementary therapy alongside standard diabetes medications, but this is speculative at this stage. Confidence level: Low, because this is animal research only.
Researchers studying natural compounds for diabetes should pay attention to these findings. People with diabetes or liver disease might find this interesting but should not attempt to use Hellenia speciosa products as a treatment without medical supervision. Healthcare providers may want to monitor future research on this plant. People interested in traditional medicine and modern science may appreciate how this study bridges both approaches.
In rats, the improvements appeared within six weeks. If this plant extract eventually reaches human trials, it would likely take several years to determine safe doses, optimal timing, and long-term effects. Any therapeutic use in humans is likely years away and depends on successful human clinical trials.
Frequently Asked Questions
Can I use Hellenia speciosa extract to treat my diabetes instead of metformin?
No. This research is only in rats, not humans. The plant extract is not approved as a diabetes treatment. Continue taking metformin or other prescribed diabetes medications as directed by your doctor. Do not stop or replace medications without medical guidance.
Does this plant extract protect the liver in people with diabetes?
Unknown. This study showed liver protection in rats, but animal results do not always apply to humans. Human clinical trials are needed to determine if the extract is safe and effective in people. No human studies have been completed yet.
Where can I buy Hellenia speciosa extract for diabetes?
The extract tested in this research is not commercially available as a medical product. Some traditional medicine suppliers may sell Hellenia speciosa products, but these are not regulated or proven effective for diabetes. Consult your doctor before using any herbal products, as they may interact with diabetes medications.
How long would it take to see benefits from this plant extract?
In rats, improvements appeared within six weeks. However, human responses may differ. If this extract eventually becomes available as a treatment, benefits would depend on individual factors, dose, and how long you use it. Your doctor would need to monitor your response.
Is Hellenia speciosa safe for people with diabetes and liver disease?
Safety in humans is unknown. This study used a very high dose in rats. Traditional medicine uses lower doses, but safety and effectiveness at any dose in humans have not been tested. Always consult your doctor before using herbal products, especially if you have liver disease or take diabetes medications.
Want to Apply This Research?
- Users could track liver health markers if they have diabetes: record fasting blood glucose levels weekly, monitor energy levels daily on a 1-10 scale, and note any changes in digestion or appetite. If this plant extract becomes available, users could log doses and correlate with these markers.
- While waiting for human research, users with diabetes can optimize liver health through proven methods: reduce high-fat foods, increase physical activity to 150 minutes weekly, maintain healthy weight, and take prescribed diabetes medications consistently. Users could set reminders to track these behaviors in the app.
- Create a dashboard showing blood sugar trends, liver enzyme results from doctor visits, and lifestyle factors like diet quality and exercise. Set monthly check-ins to review progress. When new research on this plant extract emerges, users can update their knowledge base and discuss findings with their healthcare provider.
This research was conducted in rats and has not been tested in humans. The plant extract discussed is not approved by the FDA or other regulatory agencies for treating diabetes or liver disease. People with diabetes should not use this extract as a replacement for prescribed medications. Always consult with a healthcare provider before starting any herbal supplement, especially if you take diabetes medications, as interactions may occur. This article summarizes research findings and does not constitute medical advice. Individual results may vary, and more human research is needed before any therapeutic recommendations can be made.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.